Previous close | 55.05 |
Open | 55.05 |
Bid | 56.05 |
Ask | 61.30 |
Strike | 125.00 |
Expiry date | 2025-01-17 |
Day's range | 55.05 - 55.05 |
Contract range | N/A |
Volume | |
Open interest | 123 |
Yahoo Finance’s Anjalee Khemlani joins the Live show to discuss Moderna CEO Stephane Bancel’s testimony before the U.S. Senate health committee.
Moderna's (NASDAQ: MRNA) success in the coronavirus vaccine race has equaled success for early investors. Let's take a look at how much you would have today if you'd invested $5,000 in Moderna back in 2020. Moderna became one of the first to bring a coronavirus vaccine candidate into clinical trials.
Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.